3 Things In Biotech, July 3: Roche Scores Another Big Win In IO [Seeking Alpha]
NEWLINK GENETICS (NLNK)
Last newlink genetics earnings: 2/28 09:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.linkp.com/investor-relations
Company Research
Source: Seeking Alpha
Summary Roche goes for a knockout with positive triple-negative data. NewLink hanging on and providing small updates in the IDO space. Alkermes sticks the landing in schizophrenia. Welcome to another edition of 3 Things In Biotech, a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Roche goes for a knockout with positive triple-negative data Company: Roche ( OTCQX:RHHBF ) ( OTCQX:RHHBY ) Therapy: Atezolizumab Disease: Breast cancer News: RHHBF announced positive top-line data from its IMpassion130 study, a phase 3, randomized trial evaluating the benefit of the PD-L1 inhibitor atezolizumab (Tecentriq) in combination with Celgene's ( CELG ) nab-paclitaxel (Abraxane) in women with triple-negative breast cancer. As it turns out, the combo significantly reduced the risk of progression, both in the overall population as well as in patients with higher PD-L1 expression. Looking forwar
Show less
Read more
Impact Snapshot
Event Time:
NLNK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NLNK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NLNK alerts
High impacting NEWLINK GENETICS news events
Weekly update
A roundup of the hottest topics